Large-scale testing (Phase 3)Study completedNCT05795153
What this trial is testing
A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.
Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 144